Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 7 studies | 30% ± 9% | |
endothelial cell | 6 studies | 22% ± 6% | |
astrocyte | 4 studies | 31% ± 7% | |
ciliated cell | 3 studies | 23% ± 4% | |
hepatocyte | 3 studies | 30% ± 18% | |
GABAergic neuron | 3 studies | 45% ± 2% | |
glutamatergic neuron | 3 studies | 49% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 6% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 22% ± 5% | |
basal cell | 3 studies | 27% ± 4% | |
transit amplifying cell | 3 studies | 24% ± 7% | |
oligodendrocyte | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1837.20 | 653 / 653 | 100% | 34.99 | 604 / 605 |
prostate | 100% | 915.31 | 245 / 245 | 100% | 26.05 | 501 / 502 |
uterus | 100% | 803.78 | 170 / 170 | 99% | 23.02 | 456 / 459 |
stomach | 100% | 751.02 | 359 / 359 | 99% | 27.08 | 284 / 286 |
breast | 100% | 860.23 | 459 / 459 | 99% | 22.46 | 1110 / 1118 |
kidney | 100% | 1135.03 | 89 / 89 | 99% | 22.40 | 894 / 901 |
adrenal gland | 100% | 2012.84 | 258 / 258 | 99% | 20.04 | 228 / 230 |
ovary | 100% | 591.23 | 180 / 180 | 99% | 22.90 | 426 / 430 |
intestine | 100% | 1058.40 | 966 / 966 | 99% | 29.60 | 522 / 527 |
pancreas | 100% | 666.72 | 328 / 328 | 99% | 16.75 | 176 / 178 |
bladder | 100% | 791.95 | 21 / 21 | 99% | 21.57 | 498 / 504 |
liver | 100% | 1072.46 | 226 / 226 | 99% | 16.59 | 401 / 406 |
brain | 100% | 684.35 | 2638 / 2642 | 99% | 16.36 | 695 / 705 |
lung | 99% | 684.38 | 574 / 578 | 98% | 21.65 | 1135 / 1155 |
esophagus | 100% | 866.64 | 1445 / 1445 | 97% | 20.91 | 178 / 183 |
skin | 100% | 939.90 | 1809 / 1809 | 90% | 15.25 | 424 / 472 |
adipose | 100% | 803.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.81 | 29 / 29 |
spleen | 100% | 833.40 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.80 | 1 / 1 |
blood vessel | 100% | 846.97 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 501.28 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 457.43 | 825 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 9.61 | 62 / 80 |
peripheral blood | 49% | 506.21 | 452 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_2001268 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
Gene name | CAAP1 |
Protein name | Caspase activity and apoptosis inhibitor 1 Caspase activity and apoptosis inhibitor 1 (Conserved anti-apoptotic protein) (CAAP) |
Synonyms | CAAP C9orf82 |
Description | FUNCTION: Anti-apoptotic protein that modulates a caspase-10 dependent mitochondrial caspase-3/9 feedback amplification loop. . |
Accessions | A0A3B3ISJ3 Q9H8G2 ENST00000520187.1 ENST00000483493.6 E5RFW3 ENST00000333916.8 [Q9H8G2-1] ENST00000650615.1 ENST00000625311.1 [Q9H8G2-2] E5RFV1 |